-

Benson Hill Announces Date of Fourth Quarter and Full Year Earnings Release

ST. LOUIS--(BUSINESS WIRE)--Benson Hill, Inc. (NYSE: BHIL, the “Company” or “Benson Hill”), an ag tech company unlocking the natural genetic diversity of plants, announced today that it will release its financial results for the full year and fourth quarter ending Dec. 31, 2023, before the market opens on Thursday, March 14, 2024.

The Company will host a webcast to discuss the results at 8:30 a.m. Eastern Time, including a presentation by management followed by a Q&A session. The March 14 webcast will be posted on Benson Hill’s investor relations website at https://investors.bensonhill.com.

Benson Hill also expects to file its 2023 audited financial statements within its Annual Report on Form 10-K by March 14, 2024.

About Benson Hill

Benson Hill moves food forward with the CropOS® platform, a cutting-edge food innovation engine that combines data science and machine learning with biology and genetics. Benson Hill empowers innovators to unlock nature’s genetic diversity from plant to plate, with the purpose of creating nutritious, great-tasting food and ingredient options that are both widely accessible and sustainable. More information can be found at bensonhill.com or on X, formerly known as Twitter, at @bensonhillinc.

Contacts

Investor Contact
Tana Murphy
314-579-3184
Investors@bensonhill.com

Media Contact
Christi Dixon
636-359-0797
cdixon@bensonhill.com
Media Kit

Benson Hill, Inc.

NYSE:BHIL

Release Summary
Benson Hill (BHIL) will release financial results for the full year and fourth quarter ending Dec. 31, 2023, on Thursday, March 14, 2024.
Release Versions
$Cashtags

Contacts

Investor Contact
Tana Murphy
314-579-3184
Investors@bensonhill.com

Media Contact
Christi Dixon
636-359-0797
cdixon@bensonhill.com
Media Kit

Social Media Profiles
More News From Benson Hill, Inc.

Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA™ Soybeans Following Successful Broiler Performance Trials

ST. LOUIS--(BUSINESS WIRE)--Confluence Genetics, LLC. has received positive results from a second collaborative feeding trial with a major poultry integrator, validating the consistent performance benefits of soybean meal derived from the Company's Ultra-High Protein, Low Oligosaccharide (UHP-LO) ProVIA™ soybeans. The 42-day broiler trial replicated results from an initial study with the same integrator, demonstrating that UHP-LO soybean meal can reliably improve broiler performance while reduc...

Confluence Genetics Ultra-High Protein Low Oligosaccharide Soybeans Demonstrate Superior Performance in a Large-Scale Turkey Feeding Trial

ST. LOUIS--(BUSINESS WIRE)--Confluence Genetics, LLC, a leading seed innovation company, today announced positive results from a comprehensive 20-week turkey feeding trial conducted in collaboration with a large poultry integrator. The study validates the commercial advantages of soybean meal made from Confluence Genetics' ProVIA™ Ultra-High Protein, Low Oligosaccharide (UHP-LO) soybeans as a complete replacement for conventional soybean meal in turkey diet formulations. The large-scale trial i...

Confluence Genetics Purchases Benson Hill Assets Out of Chapter 11

ST. LOUIS--(BUSINESS WIRE)--The United States Bankruptcy Court approved the sale of the business assets of Benson Hill to Confluence Genetics, LLC....
Back to Newsroom